ArticleTranslational oncology2025

ALAD as a prognostic biomarker regulates metabolism and immune responses in renal cell carcinoma through multi-omics analysis.

Wencheng Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.